After false discovery rate-bonferroni (PFDR < .05) correction, we detected 2 risk immunophenotypes of HER2-BC: human leukocyte antigen (HLA) DR on plasmacytoid DC, activated and secreting Treg %CD4+. Here, CD4 is linked to breast cancer.